Metraipolis › archive › dc_7cc64ff5eefb

Evaluation of miR-711 as Novel Biomarker in Prostate Cancer Progression — Europe PMC PMID:28843254

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/28843254
DOI: 10.22034/apjcp.2017.18.8.2185
License (as archived): solo-consultazione
Archived: 2026-11-08T12:38:33.974Z
SHA-256 of the archived text: a8ce6cd559ac1d1cf59b6b2abc5965e0235e7b626869df7022ea85ac892e48d5
Stable URL of this page: https://metraipolis.com/documento/dc_7cc64ff5eefb

How to cite

Evaluation of miR-711 as Novel Biomarker in Prostate Cancer Progression — Europe PMC PMID:28843254 — Europe PMC (en), https://europepmc.org/article/MED/28843254 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7cc64ff5eefb (Metraipolis archive dc_7cc64ff5eefb, sha256 a8ce6cd559ac1d1cf59b6b2abc5965e0235e7b626869df7022ea85ac892e48d5)

BibTeX

@misc{dc7cc64ff5eefb,
  title = {Evaluation of miR-711 as Novel Biomarker in Prostate Cancer Progression — Europe PMC PMID:28843254},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/28843254},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7cc64ff5eefb; sha256 a8ce6cd559ac1d1cf59b6b2abc5965e0235e7b626869df7022ea85ac892e48d5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/28843254. Agents can read the archived copy with the MCP tool read_document.